Janus Henderson Group PLC Astrazeneca PLC Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,584,052 shares of AZN stock, worth $124 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,584,052

Previous 1,732,206 8.55%

Holding current value

$124 Million

Previous $117 Million 5.27%

% of portfolio

0.07%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $9.9 Million - $12 Million	-148,154 Reduced 8.55%	1,584,052 $124 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $180,099 - $205,301	2,951 Added 0.17%	1,732,206 $117 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $7.11 Million - $7.96 Million	-114,859 Reduced 6.23%	1,729,255 $116 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $28.6 Million - $31.7 Million	-441,717 Reduced 19.32%	1,844,114 $125 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $27.2 Million - $29.5 Million	-389,584 Reduced 14.56%	2,285,831 $164 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $23.8 Million - $26.9 Million	-376,276 Reduced 12.33%	2,675,415 $186 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $18.7 Million - $24.2 Million	-344,247 Reduced 10.14%	3,051,691 $207 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $10.9 Million - $28 Million	-205,992 Reduced 5.72%	3,395,938 $186 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $31.6 Million - $37.9 Million	-532,745 Reduced 12.88%	3,601,930 $238 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $140 Million - $168 Million	-2,504,400 Reduced 37.72%	4,134,675 $274 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $11.9 Million - $14.1 Million	-221,190 Reduced 3.22%	6,639,075 $387 Million
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $13.9 Million - $15.2 Million	249,632 Added 3.78%	6,860,265 $412 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $131 Million - $162 Million	2,695,337 Added 68.84%	6,610,633 $396 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $145 Million - $167 Million	3,074,084 Added 365.44%	3,915,296 $195 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $11.4 Million - $13.6 Million	235,054 Added 38.78%	841,212 $42.1 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $2.71 Million - $3.12 Million	51,045 Added 9.2%	606,158 $33.2 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $1.12 Million - $1.44 Million	-26,039 Reduced 4.48%	555,113 $29.4 Million
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $668,958 - $908,643	-17,702 Reduced 2.96%	581,152 $26 Million
Q4 2019 Feb 18, 2020	SELL	$42.46 - $50.46 $2.83 Million - $3.36 Million	-66,612 Reduced 10.01%	598,854 $29.9 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $804,767 - $912,082	-20,059 Reduced 2.93%	665,466 $29.7 Million
Q2 2019 Jul 31, 2019	BUY	$37.28 - $41.68 $177,117 - $198,021	4,751 Added 0.7%	685,525 $28.3 Million
Q1 2019 Apr 30, 2019	BUY	$35.49 - $43.02 $1.59 Million - $1.93 Million	44,942 Added 7.07%	680,774 $27.5 Million
Q4 2018 Feb 06, 2019	SELL	$36.86 - $41.49 $3.9 Million - $4.39 Million	-105,878 Reduced 14.27%	635,832 $24.1 Million
Q3 2018 Nov 09, 2018	BUY	$34.76 - $39.72 $575,799 - $657,961	16,565 Added 2.28%	741,710 $29.4 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $154,438 - $165,613	-4,470 Reduced 0.61%	725,145 $25.5 Million
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $371,835 - $413,113	11,278 Added 1.57%	729,615 $25.5 Million
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $265,127 - $287,352	-8,262 Reduced 1.14%	718,337 $24.9 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $20.7 Million - $24.3 Million	714,187 Added 5754.0%	726,599 $0
Q2 2017 Aug 17, 2017	BUY	N/A	12,412	12,412 $423,000

Others Institutions Holding AZN

# of Institutions

1,332

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $243B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Astrazeneca PLC Transaction History